These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6222388)

  • 21. Pharmacokinetics of zimelidine in humans--plasma levels and urinary excretion of zimelidine and norzimelidine after intravenous and oral administration of zimelidine.
    Love BL; Moore RG; Thomas J; Chaturvedi S
    Eur J Clin Pharmacol; 1981; 20(2):135-9. PubMed ID: 6455297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical trial of zimelidine in depression.
    Georgotas A; Mann J; Bush D; Gershon S
    Commun Psychopharmacol; 1980; 4(1):71-7. PubMed ID: 6447007
    [No Abstract]   [Full Text] [Related]  

  • 23. Zimelidine to geriatric patients: a pharmacokinetic and clinical study.
    Dehlin O; Björnsson G; Lundström J
    Acta Psychiatr Scand Suppl; 1981; 290():410-24. PubMed ID: 6452803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study of the effect of the 5-HT-uptake inhibitor, zimelidine, on phobic anxiety.
    Koczkas S; Holmberg G; Wedin L
    Acta Psychiatr Scand Suppl; 1981; 290():328-41. PubMed ID: 6452799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zimelidine in chronic suicidal behaviour.
    O'Connor M; Pettiford J
    Aust N Z J Psychiatry; 1982 Dec; 16(4):296-7. PubMed ID: 6220693
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet serotonin uptake inhibition as a basis for monitoring antidepressant drug treatment.
    Lingjaerde O
    J Clin Psychopharmacol; 1984 Apr; 4(2):76-81. PubMed ID: 6231316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder.
    Flament MF; Rapoport JL; Murphy DL; Berg CJ; Lake CR
    Arch Gen Psychiatry; 1987 Mar; 44(3):219-25. PubMed ID: 3548637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open trial of zimelidine in patients with endogenous depression.
    Kiloh LG; Moore G
    Int Pharmacopsychiatry; 1982; 17(1):28-35. PubMed ID: 6211416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Georgotas A; Krakowski M; Gershon S
    Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
    Montgomery SA; Montgomery DB; McAuley R; Rani SJ; Roy D
    Adv Biochem Psychopharmacol; 1982; 32():35-42. PubMed ID: 6211942
    [No Abstract]   [Full Text] [Related]  

  • 31. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
    Syvälahti E; Salminen J; Lehtinen V
    J Int Med Res; 1982; 10(4):250-6. PubMed ID: 6214441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual evoked potentials as a predictor of reported side effects during a trial of zimelidine vs. placebo in chronic pain patients.
    von Knorring L; Johansson F
    Psychiatry Res; 1979 Dec; 1(3):225-30. PubMed ID: 298350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of zimelidine and inhibition of uptake of 5-hydroxytryptamine in the isolated, ventilated and perfused rat lung.
    Post C; Hede AR
    Biochem Pharmacol; 1982 Oct; 31(19):3116-9. PubMed ID: 6216892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Heel RC; Morley PA; Brogden RN; Carmine AA; Speight TM; Avery GS
    Drugs; 1982 Sep; 24(3):169-206. PubMed ID: 6215240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of serotonin uptake inhibition by zimelidine on hypothalamic-pituitary-adrenal activity.
    Holsboer F; Müller OA; Winter K; Doerr HG; Sippell WG
    Psychopharmacology (Berl); 1983; 80(1):85-7. PubMed ID: 6306711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanism of the inhibiting effect of atypical antidepressants and psychostimulants on the synaptosomal uptake of monoamines].
    Gankina EM; Maĭsov NI
    Biull Eksp Biol Med; 1983 Aug; 96(8):52-4. PubMed ID: 6224517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients.
    Siwers B; Ringberger VA; Tuck JR; Sjöqvist F
    Clin Pharmacol Ther; 1977 Feb; 21(2):194-200. PubMed ID: 837638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zimelidine: a new antidepressive.
    Drug Ther Bull; 1982 Nov; 20(24):95-6. PubMed ID: 6217059
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of platelet uptake of serotonin in plasma from patients treated with clomipramine and amitriptyline.
    Lingjaerde O
    Eur J Clin Pharmacol; 1979 Jun; 15(5):335-40. PubMed ID: 456405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the augmenter-reducer tendency and in pain measures as a result of treatment with a serotonin-reuptake inhibitor--zimelidine.
    von Knorring L; Johansson F
    Neuropsychobiology; 1980; 6(6):313-8. PubMed ID: 6449679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.